42 patients, 42 valves safely implanted through calcified iliofemoral access!
Welcome to The Catalyst
Change isn't quick. Unless it's when you experience Intravascular Lithotripsy (IVL) for the first time. Stay apprised of our latest news and insights while discovering how a simple and intuitive tool can be The Catalyst to change the way you think about calcium modification.
42 patients, 42 valves safely implanted through calcified iliofemoral access!
Topics: Peripheral Clinical Data, Shockwave M5 & Shockwave M5+
New York City never stops, and as vascular surgeons know, neither do the challenges of calcium. We are very excited to attend VEITH Symposium next week, November 19 – 23, in the Big Apple to discuss the latest IVL updates in vascular intervention. To help you plan your week, we’ve pulled together some of our events that we’re looking forward to most.
Topics: Peripheral Conferences
VIVA is always one of the best peripheral meetings every year, and we’re especially excited this year because we’ve got something new to show you: Shockwave S4.
Topics: Peripheral Conferences, Shockwave S4
The complete DISRUPT CAD II study findings have been published by the AHA’s journal, Circulation: Cardiovascular Interventions, and while it’s definitely worth the full read, we know that sometimes there just aren’t enough hours in the day. For a quick synopsis, we took the liberty to summarize some of the key data points into a visual-friendly infographic for you to review some of the study’s most important findings.
Topics: Coronary Clinical Data, Shockwave C2
For international customers currently using our coronary technology, we’re happy to report that coinciding with its presentation at TCT 2019 today, the DISRUPT CAD II study has also been simultaneously published by the AHA journal, Circulation: Cardiovascular Interventions.
Topics: Coronary Clinical Data, Shockwave C2
After being held in various cities over the recent years, TCT is back home where it belongs – back in the Bay, and joyfully, right in our backyard. We couldn’t be more excited about TCT this year. And no, it’s not just because those of us who live in the city are lucky enough to walk to work for a few beautiful September days.
Topics: Shockwave C2, Coronary Conferences
The experience with Intravascular Lithotripsy in a wide variety of peripheral lesions continues to grow.
Critical limb ischemia (CLI) is the most advanced form of peripheral artery disease and often involves stenoses in calcified below-the-knee (BTK) arteries.
Topics: Shockwave S4
Thanks to our UK distributor, Vascular Perspectives, for capturing a very compelling case from Dr. Richard Anderson, one of the longest standing commercial coronary IVL users in the in the UK at the University Hospital Wales. In the video he details out his treatment strategy for treating a heavily calcified RCA, LMS, LAD and LCX with a variety of calcium modification tools, including Shockwave IVL. Learn why he chooses Shockwave as his primary tool due to the patient’s moderate to severe left ventricular impairment. Hope you enjoy the case review!
Topics: Shockwave C2
At the EPIC-SEC conference in May 2019, Dr. Chandan Devireddy performed a live case using Shockwave IVL in advance of a TAVR procedure. He tweeted about the procedure and has offered to share some additional context about the specific case, as well as the potential impact of IVL to facilitate transfemoral TAVR in the presence of calcified iliac access in general.
Topics: Shockwave M5 & Shockwave M5+
Novelist, poet, playwright, and art collector Gertrude Stein is famous for the quote, “America is my country and Paris is my hometown.” Well, that’s exactly how we felt this spring with the warm reception IVL received at EuroPCR 2019.
Topics: Shockwave C2, Coronary Conferences
But, right now we're in the early phases of the R&D program. In the meantime, don't miss the IVL application that heart teams are embracing already — maintaining transfemoral TAVR access through heavily calcified iliacs by using IVL.
